Bibo

Bengaluru, India Founded: 2019 • Age: 7 yrs Minicorn
Ayurvedic diagnostics and medicines for respiratory health are manufactured.

About Bibo

Bibo is a Healthcare company based in Bengaluru (India) founded in 2019 by Vikash Kumar. Ayurvedic diagnostics and medicines for respiratory health are manufactured. It operates on a Direct-to-Consumer (D2C) and HealthTech model. Bibo has raised $516.8 thousand across 6 funding rounds from investors including SR Innovation Exchange, Springforth Capital Advisors and Pankaj Kumar. Bibo was last valued at $1.82 million in June 2022. Its chief executive, as recorded, is Vikash Kumar. Its Indian entity Hilt Brands India Private Limited reported revenue of β‚Ή1.36 Cr. Bibo offers products and services including Bibo Saline Nasal Spray, Breathofy Syrup, Bibo Breathe Blend, and Bibo Pollution Detox Kit. Its focus areas include Respiratory Care and Nasal and Cough Remedies. Its competitors include Patanjali Ayurved, LifeChart Ayurveda and Upakarma; 3 of its 3 listed competitors have raised funding.

Company details

Bibo is focused on delivering respiratory healthcare solutions through a range of products like nasal sprays and cough syrups. The company operates in the healthcare sector, targeting conditions such as cough, cold, sinusitis, and allergies. Products are developed by blending ancient Ayurvedic wisdom with modern science, ensuring efficacy and safety. Solutions are offered directly to consumers via an online platform, primarily in India.

  • Headquarters Bengaluru, India
  • Founders Vikash Kumar
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bibo.health
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Hilt Brands India Private Limited
  • Date of Incorporation 07 Jun, 2019
  • Jurisdiction Bengaluru, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹1.36 Cr

    FY 2024 · +108% YoY

  • Net Loss
    -₹69.9 Lakh

    FY 2024 · -51% margin

  • EBITDA
    -₹69.5 Lakh

    FY 2024 · -51% margin

  • Total Equity Funding
    $516.8K (USD)

    in 6 rounds

  • Latest Funding Round
    $60.04K (USD), Seed

    Dec 2023

  • Investors

Products & Services of Bibo

Bibo offers a comprehensive portfolio of products and services, including Bibo Saline Nasal Spray, Breathofy Syrup, Bibo Breathe Blend, and Bibo Pollution Detox Kit.

Bibo Saline Nasal Spray
Healthcare

Nasal spray used for relieving blocked nose issues.

Breathofy Syrup
Healthcare

Syrup used for treating various types of coughs.

Bibo Breathe Blend
Healthcare

Aroma therapy blend used for steam and diffuser.

Bibo Pollution Detox Kit
Healthcare

Kit used for rejuvenation with natural detox products.

Apps and channels of Bibo

its YouTube channel Bibo - Breathing & Flu Innovations has 11.1K subscribers and 30 videos.

Bibo - Breathing & Flu Innovations
YouTube 11.1K subscribers 30 videos Howto & Style
Open channel

Videos from Bibo

The most watched videos on Bibo's YouTube channel, Bibo - Breathing & Flu Innovations (11.1K subscribers). Click a video to play it here.

Easy steps to recover from Pneumonia
7.1K views
Why Does the Flu Cause Body Aches?
393 views
Breathe Easy - Your Guide to Respiratory Health | BIBO HEALTH
329 views
How to prevent and treat Cold Induced Asthma?
318 views

More on Bibo - Breathing & Flu Innovations .

Funding Insights of Bibo

Bibo has successfully raised a total of $516.8K across 6 strategic funding rounds. The most recent funding activity was a Seed round of $60.04 thousand completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $516,804
  • Total Rounds 6
  • Last Round Seed β€” $60,038
  • First Round $84,880

    (Aug 2019)

  • Investors Count 34

All 6 funding rounds of Bibo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$60,038Seed–Springforth Capital Advisors
May 2023$42,341Angel Round––
Jun 2022$116,109Angel Round$1.82MRajesh Singh
Jan 2022$150,000Seed$1.26Mah! Ventures, SR Innovation Exchange
–
Apr 2020$63,436Angel Round$β€’β€’β€’β€’β€’Sanchit Agarwal, Suman Kumar
Aug 2019$84,880Angel Round$β€’β€’β€’β€’β€’Anand Anupam, Rabindra Mohan Das
Valuation history
DateValuationStage
Jun 2022$1.82Mβ€’β€’β€’β€’β€’β€’β€’β€’
Jan 2022$1.26Mβ€’β€’β€’β€’β€’β€’β€’β€’
Apr 2020$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Aug 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Bibo

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $1.82M (Jun 2022). 34 investors in total: 3 institutional and 31 angel.

Investors in Bibo

Bibo has secured backing from 34 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include SR Innovation Exchange, Springforth Capital Advisors and Pankaj Kumar.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Innovation and entrepreneurship support through incubation and programs.
2017srix.inWarangal, India
Investment banking and advisory services are provided by Springforth Capital Advisors, focusing on finance and consulting for various sectors.
2012springforthcap.comHyderabad, India
Fundraising is enabled for startups through an investor connection platform.
ahventures.inMumbai, India

Pankaj Kumar

unknown_a2e5a02c3132464d9

Swati Sinha

unknown_a07189c299fb47adb

Rabindra Mohan Das

unknown_6dd0c1f5f0774ab7b

Kirandeep Singh

unknown_fc5c6c6e14f44d298

Nishant Nehru

unknown_ebf7b8b01dee48968

Usha Sharma

unknown_384a8cfdef5a448cb

Rajesh Singh

unknown_29375bf15dca43cd9
Premium access

Investor details for Bibo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Hilt Brands India Private Limited (Bibo)

Hilt Brands India Private Limited is the primary company behind Bibo. The board of Hilt Brands India Private Limited currently have 4 directors; the longest-serving is Vikash Kumar, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Vikash Kumar
DIN 06816372
Managing Director07 Jun 20197 yrs 5 moHilt Brands India Private Limited
Rashmi Prabha
DIN 08474444
Director07 Jun 20197 yrs 5 moHilt Brands India Private Limited
Ruby Singh
DIN 08690571
Director20 Mar 20206 yrs 7 moHilt Brands India Private Limited
Anand Anupam
DIN 01946734
Director20 Mar 20206 yrs 7 moHilt Brands India Private Limited

People of Bibo

2 people are tracked at Bibo (2 in leadership).

NameRoleGroup
Co-Founder & CEOLeadership
Shreya Shree
Design And Social HeadLeadership
Premium access

Complete people profiles for Bibo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Bibo

Figures of Hilt Brands India Private Limited, the primary company behind Bibo, for FY 2024. Revenue was ₹1.36 Cr (+108% year on year). Net loss was -₹69.9 Lakh (-51% margin). EBITDA was -₹69.5 Lakh (-51% margin). Revenue has grown at a compounded annual rate of +15% over three years.

  • ₹1.36 CrRevenue · FY 2024 · +108% YoY
  • -₹69.9 LakhNet loss · -51% margin
  • -₹69.5 LakhEBITDA · -51% margin
  • ₹1.4 LakhPaid-up capital
  • +15%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Hilt Brands India Private Limited are on its company page.

Premium access

Detailed financial statements for Bibo

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Bibo

4 dated milestones of Bibo across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bibo is founded.
  2. Funding First funding round of $85K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $60K.

Competitors of Bibo

Bibo has 3 listed competitors in our database, 3 of them funded. They include Patanjali Ayurved, LifeChart Ayurveda and Upakarma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
patanjaliayurved.net2006Haridwar, India$430,6241,460
Ayurvedic medicines and nutraceuticals are offered via an online platform.
lifechartayurveda.in2022Gurugram, India$1.06M
Gut health-tech company developing ayurvedic healthcare solutions
upakarma.com2017Delhi, India$55,8223
Internet first D2C brand offering ayurvedic health, beauty, immunity & wellness products
Premium access

Detailed competitors of Bibo

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bibo

The website of Bibo (bibo.health) receives about 3.8K visits a month.

  • Monthly visits
    3.8K

    ▼ 31.8% vs previous month

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Bibo (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 199.65 MUSD 328.97 M5,212
Online platform offering multiple healthcare services
2013Bengaluru, Karnataka, IndiaUSD 199.22 MUSD 89.83 M4,231
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 MUSD 132.33 M1,344
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bibo

Bibo was founded in 2019.

Bibo is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Vikash Kumar is the CEO of Bibo, as recorded in our data. They have also founded this company.

Bibo is a funded company, having raised a total of $516.8K across 6 funding rounds to date. The company's 1st funding round was a Angel Round of $84.88K, raised on Aug 2019.

The primary company behind Bibo, Hilt Brands India Private Limited, reported revenue of β‚Ή1.36 Cr for FY 2024, up 108% year on year.

Bibo is focused on delivering respiratory healthcare solutions through a range of products like nasal sprays and cough syrups. The company operates in the healthcare sector, targeting conditions such as cough, cold, sinusitis, and allergies. Products are developed by blending ancient Ayurvedic wisdom with modern science, ensuring efficacy and safety. Solutions are offered directly to consumers via an online platform, primarily in India.

Bibo's top competitors include Patanjali Ayurved, LifeChart Ayurveda and Upakarma.

Bibo offers Bibo Saline Nasal Spray, Breathofy Syrup, Bibo Breathe Blend, and Bibo Pollution Detox Kit.

Bibo has 34 investors. Key investors include SR Innovation Exchange, Springforth Capital Advisors, Pankaj Kumar, Swati Sinha, and Rabindra Mohan Das.

The valuation of Bibo is $1.82M as of Jun 2022.

Bibo operates through Hilt Brands India Private Limited.

The legal entities of Bibo currently have 4 directors, including Vikash Kumar, Rashmi Prabha, Ruby Singh and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available